admin

With the market in correction mode, investors have the opportunity to buy some of the biggest technology trends at more reasonable valuations. The recent ransomware attack on Colonial Pipeline has one recurrent investment theme back in the spotlight: cybersecurity. The $162 billion cybersecurity market is expected to grow at a compound annual growth rate (CAGR)
0 Comments
There have been increasing concerns about accelerating inflation in the United States. The latest data indicate that consumer prices in the U.S. increased the most since fiscal year 2009. The policy response to rising inflation also seems uncertain. Recently, Treasury Secretary Janet Yellen said that “she wasn’t forecasting interest-rate increases to rein in any inflation.”
0 Comments
Thousands of stocks pay dividends, which can make choosing among them difficult, but there are some aspects of dividend stocks that are particularly attractive. One factor that can make a big difference is competitive advantage and leadership in a given industry. In general, larger companies with global dominance are considered safer and typically have more
0 Comments
Buying Luminar Technologies (NASDAQ:LAZR) stock is a bet that Light Detection and Ranging  (Lidar) will become the standard for making vehicles safe and even autonomous. Source: JHVEPhoto/shutterstock.com It’s also a bet on 26-year old Austin Russell, a California native who took Luminar public in December through a SPAC called Gores Metropoulos. LAZR stock shot out
0 Comments
It’s abundantly clear that the Reddit-driven rallies in names like Sundial Growers (NASDAQ:SNDL) stock went too far. The supposedly epic “short squeezes” promised since late January haven’t materialized. GameStop (NYSE:GME), AMC Entertainment (NYSE:AMC), SNDL stock and others remain well off their peaks. There’s plenty of reason for skepticism toward those names going forward as well.
0 Comments
The disruption that the novel coronavirus caused last year was nothing like we’ve had in centuries. Luckily, we have amazing vaccine companies that succeeded, plus others like Novavax (NASDAQ:NVAX) trying their hardest. NVAX stock is still full of potential and today we will debate owning it. Source: Ascannio/Shutterstock.com Pfizer (NYSE:PFE), Moderna (NASDAQ:MRNA) and AstraZeneca (NASDAQ:AZN)
0 Comments
For many digital currency enthusiasts, bitcoin and ethereum occupy central spaces as focal points. Beyond this, amateur investors may be aware of other cryptocurrencies like ripple or EOS, and they may also be familiar with gimmick tokens like dogecoin. Some of the other major digital currencies are often neglected, however; litecoin tends to be one
0 Comments
In this crazy market environment where bearishness equates to a reason to buy a particular equity unit, it should be no surprise in this context that Zomedica (NYSEAMERICAN:ZOM) previously dominated the charts. Given that ZOM stock once closed near the $3 level, shares at less than 80 cents sounds like a reasonable opportunity. But if
0 Comments